Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 119-125 , November 2005

Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus

  • Giuseppe Derosa

      Affiliations

    • Department of Internal Medicine and Therapeutics, University of Pavia, P. le C. Golgi 2, 27100 Pavia, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0382 526217; fax: +39 0382 526259.
    • ,
  • Maria A. Avanzini

      Affiliations

    • Research Laboratories for Pediatric Oncohematology and Immunology, IRCCS Policlinico S. Matteo, Pavia, Italy
    • ,
  • Diego Geroldi

      Affiliations

    • Department of Internal Medicine and Therapeutics, University of Pavia, P. le C. Golgi 2, 27100 Pavia, Italy
    • ,
  • Roberto Fogari

      Affiliations

    • Department of Internal Medicine and Therapeutics, University of Pavia, P. le C. Golgi 2, 27100 Pavia, Italy
    • ,
  • Renata Lorini

      Affiliations

    • Department of Pediatrics, University of Genova, G. Gaslini Institute, Genova, Italy
    • ,
  • Annalisa De Silvestri

      Affiliations

    • Biometric Unit, IRCCS Policlinico S. Matteo, Pavia, Italy
    • ,
  • Carmine Tinelli

      Affiliations

    • Biometric Unit, IRCCS Policlinico S. Matteo, Pavia, Italy
    • ,
  • Giorgio Rondini

      Affiliations

    • Biometric Unit, IRCCS Policlinico S. Matteo, Pavia, Italy
    • ,
  • Giuseppe d’Annunzio

      Affiliations

    • Research Laboratories for Pediatric Oncohematology and Immunology, IRCCS Policlinico S. Matteo, Pavia, Italy
    • Biometric Unit, IRCCS Policlinico S. Matteo, Pavia, Italy

Received 24 August 2004 ,Revised 14 February 2005 ,Accepted 4 March 2005.

References 

  1. Law GR, McKinney PA, Staines A. Clustering of childhood IDDM links with age and place of residence. Diabetes Care. 1997;20:753–756
  2. Nathan DM. Long-term complications of diabetes mellitus. N. Engl. J. Med. 1993;328:1676–1684
  3. Pomilio MP, Mohn A, Verrotti A, Chiarelli F. Endothelial dysfunction in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 2002;15:343–361
  4. Quinn M, Angelico MC, Warram JH, Krowleski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940–945
  5. Kalter-Leibovici O, Laron Z. Vascular complications childhood diabetes mellitus. Curr. Opin. Pediatr. 1992;4:685–694
  6. Donaghue KC, Fairchild JM, Chan A, Hing SJ, Howard NJ, Silink M. Diabetes complications in 937 children and adolescents. J. Pediatr. Endocrinol. Metab. 1999;12:185–192
  7. The Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986
  8. Bojestig M, Arnqvist HJ, Hermansson G, Kalrlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1994;330:15–18
  9. Mortensen HB, Robertson KJ, Aanstoot HJ. For the Hvidore Study Group of Childhood Diabetes Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Diabetes Med. 1998;15:752–759
  10. Lawson M, Frank MR, Fry MK, Pelman K, Sochett EB, Daneman D. Intensive diabetes management in adolescents with type 1 diabetes: the importance of intensive follow-up. J. Pediatr. Endocrinol. Metab. 2000;13:79–84
  11. Friedman EA. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care. 1999;22:B65–B71
  12. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 1995;77:863–868
  13. McLennan SV, Fisher E, Martell SY. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int. (Suppl.). 2000;77:S81–S87
  14. ISPAD Consensus Guidelines for the Management of Type 1 Diabetes Mellitus in Children and Adolescents, 2000.
  15. Moglia A, Lorini R, D’Annunzio G, Lanzi G, Berardinelli A, Zandrini C. Clinical and neurophysiological study in diabetic children and adolescents. Funct. Neurol. 1994;9:75–82
  16. Romano M, Pomilio M, Vigneri S. Endothelial perturbation in children and adolescents in type 1 diabetes. Association with markers of the inflammatory reaction. Diabetes Care. 2001;24:1674–1678
  17. Elhadd TA, Kennedy G, Hill A. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab. Res. Rev. 1999;15:405–411
  18. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–126
  19. Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor. Prog. Cardiovasc. Dis. 1984;26:373–412
  20. Uemura S, Matsushita H, Li W. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 2001;88:1291–1298
  21. Maxwell PR, Timms PM, Chandran S, Gordon D. Peripheral blood level alterations of TIMP-1 MMP-2 and MMP-9 in patients with type 1 diabetes. Diabetes Med. 2001;18:777–780
  22. Diamant M, Hanemaaijer R, Verheijen JH, Smit JW, Radder JK, Lemkes HH. Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabetes Med. 2001;18:423–424
  23. Maeda S, Haneda M, Guo B. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 is associated with diabetic nephropathy. Kidney Int. 2001;60:1428–1434
  24. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture. Players keep piling up but questions remain. Circulation. 2001;104:1878–1880
  25. Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation. 2002;106:679–684

PII: S0168-8227(05)00095-1

doi: 10.1016/j.diabres.2005.03.020

Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 119-125 , November 2005

Article Tools

* Image Usage & Resolution